- Adrenocorticosteroids and Fetal Lung
Maturation
- Lung maturation is dependent
on fetal cortisol
- If delivery is expected
before 34 weeks gestation, maternal
glucocorticoid supplementation reduces
likelihood of respiratory distress
syndrome.
- Betamethasone (Celestone)
preferred due to reduced protein binding
-- making more available for placental
transfer to the fetal circulation.
return to main menu
Adrenocorticosteroids in treatment of
nonadrenal disorders
Disorder |
Some
Examples |
Allergic reactions
|
angioneurotic
edema, asthma, contact dermatitis, drug
reactions, allergic rhinitis, urticaria |
Collagen-vascular pathology
|
giant cell
arteritis, lupus erythematosus, polymyositis,
rheumatoid arthritis, temporal arteritis |
Eye
diseases |
allergic
conjunctivitis, optic neuritis |
Gastrointestinal |
inflammatory bowel
disease than |
Hematologic |
acute allergic
purpura, leukemia, autoimmune hemolytic anemia,
idiopathic thrombocytopenic purpura, multiple
myeloma |
Infections |
gram-negative
septicemia and |
Inflammatory
disorders of joints/bones |
arthritis,
bursitis,tenosynovitis |
Neurologic |
cerebral edema,
multiple sclerosis |
Organ
Transplantation |
prevention/treatment
of rejection (immunosuppression) |
Pulmonary |
bronchial asthma,
prevention of infant respiratory
distress,sarcoidosis, aspiration pneumonia |
Renal |
nephrotic syndrome |
Skin |
atopic dermatitis,
dermatoses, mycoses fungoides, seborrheic
dermatitis |
Thyroid |
malignant
exophthalmos, subacute thyroiditis |
adapted from Table 39-2; Goldfien,
A.,Adrenocorticosteroids and Adrenocortical
Antagonists, in Basic and Clinical Pharmacology,
(Katzung, B. G., ed) Appleton-Lange, 1998, p 643. |
- Glucocorticoid
Toxicity
- Metabolic
Effects
- iatrogenic Cushing's
syndrome
- moon
facies
- fat
redistribution; e.g.
truncal obesity
- acne
- hirsuitism
-
insomnia, increased
appetite
- weight
gain
- muscle
wasting
- skin
thinning, bruising
- hyperglycemia
- osteoporosis,
diabetes, aseptic hip
necrosis
- wound
healing
return to main menu
- Other
Effects:
- peptic
ulcer development
- myopathy
(triamcinolone)
- nausea,
dizziness, weight loss
(triamcinolone,
methylprednisolone)
- psychosis
(large dose corticosteroids)
- subcapsular
cataracts
- increased
intraocular pressure/glaucoma
- benign
intracranial hypertension
- growth
retardation and children
- cortisone/hydrocortisone
in greater than physiologic
amounts: mineralocorticoid
effects:
- sodium/fluid
retention
- potassium
loss-- hypokalemia
- hypochloremic
alkalosis
- hypertension
- Adrenal Suppression
- significant
adrenal suppression observed with
extended treatment
- patient
should receive supplemental
steroid in cases of accidental
trauma/surgery
- the
presence of adrenal suppression
requires slow tapering of
adrenocorticoid dosage
- Precautions
- patient should be
observed to detect development
of:
- hyperglycemia
- glycosuria
- Na
retention with edema
- hypertension
- hypokalemia
- peptic
ulcer
- osteoporosis
- hidden
infections
return to main menu
- Contraindications:
- peptic
ulcer disease
- heart
disease/hypertension with
congestive heart failure
- psychoses
- diabetes
- osteoporosis
- glaucoma
- herpes
simplex infection
return to main menu
|